Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous Tumor”

503 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 503 results

Testing effectiveness (Phase 2)Looking for participantsNCT04787042
What this trial is testing

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Who this might be right for
CancerSolid TumorMelanoma+6 more
Simcha IL-18, Inc. 316
Large-scale testing (Phase 3)Ended earlyNCT00125801
What this trial is testing

The Pain Pen for Breakthrough Cancer Pain

Who this might be right for
NeoplasmsPain
Erasmus Medical Center 50
Large-scale testing (Phase 3)Study completedNCT01384877
What this trial is testing

Subcutaneous Lidocaine For Cancer-Related Pain

Who this might be right for
Cancer-related Pain
British Columbia Cancer Agency 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT04521231
What this trial is testing

Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

Who this might be right for
B Cell Precursor Acute Lymphoblastic Leukemia
Amgen 181
Not applicableStudy completedNCT07667712
What this trial is testing

Effect of Buzzy®, Cognitive Behavioral Intervention, and Kaleidoscope During SC Injection in Children With Cancer

Who this might be right for
Pediatric CancerProcedural PainProcedural Fear in Children+1 more
Kocaeli University 45
Early research (Phase 1)Study completedNCT00411580
What this trial is testing

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT05283720
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Genmab 264
Large-scale testing (Phase 3)Active Not RecruitingNCT05578976
What this trial is testing

Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Genmab 900
Testing effectiveness (Phase 2)Study completedNCT00274976
What this trial is testing

Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine

Who this might be right for
Leukemia
German CLL Study Group
Testing effectiveness (Phase 2)Study completedNCT00565981
What this trial is testing

A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response

Who this might be right for
B-cell Chronic Lymphocytic Leukemia
Arbeitsgemeinschaft medikamentoese Tumortherapie 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07301424
What this trial is testing

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)BCR-ABL Positive Acute Lymphoblastic Leukemia
University of Alberta 80
Testing effectiveness (Phase 2)UnknownNCT05370235
What this trial is testing

Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V

Who this might be right for
Xeroderma Pigmentosum
Clinuvel Europe Limited 6
Testing effectiveness (Phase 2)Looking for participantsNCT06116682
What this trial is testing

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Who this might be right for
Lung Non-Small Cell Carcinoma
SWOG Cancer Research Network 88
Large-scale testing (Phase 3)Study completedNCT01940497
What this trial is testing

The Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 240
Large-scale testing (Phase 3)Looking for participantsNCT06641089
What this trial is testing

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Who this might be right for
Arthritis, Psoriatic
MoonLake Immunotherapeutics AG 600
Testing effectiveness (Phase 2)Looking for participantsNCT07227350
What this trial is testing

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Philogen S.p.A. 180
Early research (Phase 1)Study completedNCT00652626
What this trial is testing

Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function

Who this might be right for
MDSAMLSolid Tumors+3 more
Celgene 31
Large-scale testing (Phase 3)UnknownNCT02830685
What this trial is testing

Pre-pectoral Breast Reconstruction PART 1

Who this might be right for
Breast Cancer
Guy's and St Thomas' NHS Foundation Trust 131
Large-scale testing (Phase 3)Study completedNCT00726011
What this trial is testing

Tetrodotoxin Open-label Efficacy and Safety Continuation Study

Who this might be right for
PainCancer
Wex Pharmaceuticals Inc. 113
Early research (Phase 1)Looking for participantsNCT06598306
What this trial is testing

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Amgen 220
Next Page